• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Auto-injectors

Embecta eyes shift from insulin delivery to broader medical supplies focus

May 22, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications. The pure-play diabetes technology company has endured ups and downs since its 2022 spin-off from BD. That includes an FDA approval for a disposable insulin patch pump system in September 2024, only to be followed by the discontinuation […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Wall Street Beat Tagged With: embecta

Embecta to undergo further restructuring, lowers guidance amid tariff impact

May 9, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Embecta (Nasdaq:EMBC) stock was down today after news of restructuring and mixed second-quarter results. Shares of EMBC were down more than 8% to $12.12 apiece near the close of trading today. While the company continues to work through the discontinuation of its insulin patch pump program — the plan for which it says is substantially […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Technology Tagged With: embecta

IDE Group launches ophthalmic auto-injector

May 5, 2025 By Sean Whooley

IDE Group OKO auto-injector

IDE Group recently unveiled OKO, its new ophthalmic auto-injector for improving drug delivery precision and efficiency. The company says OKO addresses critical unmet needs in ophthalmology. It aims to improve precision, procedural efficiency and patient safety compared to existing adapted injection methods. Currently, intravitreal injections — essential injections for treating retinal diseases like wet age-related […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Optical/Ophthalmic Tagged With: IDE Group

Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation

January 16, 2025 By Sean Whooley

BD Diabetes Spinoff Embecta

Analysts called a recent stock sell-off at Embecta (Nasdaq:EMBC) “unwarranted” and believe the company is moving in the right direction despite recent challenges. Late last year, Embecta filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. This related to the company’s plans to discontinue its insulin patch pump program and restructure. […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pharmaceuticals, Technology, Wall Street Beat Tagged With: embecta

Ypsomed, BD collab on self-injection systems for high-viscosity biologics

October 23, 2024 By Sean Whooley

BD NeoPak prefillable syringe Ypsomed YpsoMate auto-injector

BD (NYSE:BDX) and Ypsomed today announced a strategic collaboration to advance self-injection solutions for high-viscosity biologic drugs. In a joint project, the companies pre-assessed and streamlined the integration of the BD Neopak XtraFlow glass prefillable syringe with the Ypsomed YpsoMate 2.25 auto-injector platform. They aim to address current limitations by enabling the delivery of higher-viscosity […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Pharmaceuticals Tagged With: BD, Ypsomed

Ypsomed increases auto-injector production in Germany

October 17, 2024 By Sean Whooley

Ypsomed Schwerin auto-injector facility

Ypsomed announced today that it opened a new production hall at its German site in Schwerin to increase auto-injector production. The Burgdorf, Switzerland-based company said its expansion enables an increase in production capacity to meet growing global demand. CEO Simon Michel also said the company plans to further expand the plant in the coming years. […]

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured Tagged With: Ypsomed

The 9 largest diabetes technology companies in the world

August 21, 2024 By Sean Whooley

9 largest diabetes companies in the world abbott dexcom medtronic insulet

Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: abbott, Dexcom, embecta, Insulet, Medtronic, Roche Diabetes Care, Senseonics, Tandem Diabetes Care, Ypsomed

FDA approves first opioid overdose reversal auto-injector from Purdue Pharma

August 8, 2024 By Sean Whooley

Purdue Pharma Logo

Purdue Pharma announced that the FDA approved its new drug application (NDA) for the Zurnai (nalmefene injection) auto-injector. The single-dose auto-injector delivers 1.5 mg of nalmefene hydrochloride per actuation. It marks the approved first nalmefene hydrochloride auto-injector for the emergency treatment of known or suspected opioid overdose. The agency approved the first nasal spray formulation […]

Filed Under: Auto-injectors, Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceuticals Tagged With: FDA, purduepharma

Ypsomed closes pen needle, BGM business sale to focus on insulin pump

August 2, 2024 By Sean Whooley

Ypsomed Logo 770x500

Ypsomed announced today that it completed the sale of its pen needle and blood glucose monitoring (BGM) businesses to Medical Technology and Devices (MTD). The Burgdorf, Switzerland-based company first announced an agreement to sell off those businesses to MTD in March. Ypsomed plans to support a reliable transition to ensure pen needle supply amid the […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions Tagged With: Ypsomed

Ypsomed inks autoinjector deal with German pharma company Medac

June 12, 2024 By Sean Whooley

Ypsomed metoject autoinjector pen

Ypsomed announced that German company Medac selected its autoinjector technology for the relaunch of its methotrexate pen. The YpsoMate 1.0 will gradually replace the current available metoject/metex pen for the German company’s methotrexate products. Ypsomed launched its new autoinjector in various countries during the first quarter of this year. Medac develops subcutaneous methotrexate (MTX) products, […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Ypsomed

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 33
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS